1. Home
  2. ARTNA vs LCTX Comparison

ARTNA vs LCTX Comparison

Compare ARTNA & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artesian Resources Corporation

ARTNA

Artesian Resources Corporation

HOLD

Current Price

$33.37

Market Cap

337.4M

Sector

Utilities

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.28

Market Cap

301.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARTNA
LCTX
Founded
1905
1990
Country
United States
United States
Employees
274
N/A
Industry
Water Supply
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
337.4M
301.7M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
ARTNA
LCTX
Price
$33.37
$1.28
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$6.25
AVG Volume (30 Days)
26.0K
1.1M
Earning Date
05-12-2026
05-14-2026
Dividend Yield
3.99%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$14,556,000.00
Revenue This Year
$7.82
$109.40
Revenue Next Year
$3.54
N/A
P/E Ratio
$15.23
N/A
Revenue Growth
N/A
53.24
52 Week Low
$30.50
$0.85
52 Week High
$34.90
$2.09

Technical Indicators

Market Signals
Indicator
ARTNA
LCTX
Relative Strength Index (RSI) 62.71 51.14
Support Level $31.86 N/A
Resistance Level $33.79 $1.32
Average True Range (ATR) 0.68 0.07
MACD 0.07 0.01
Stochastic Oscillator 97.06 72.52

Price Performance

Historical Comparison
ARTNA
LCTX

About ARTNA Artesian Resources Corporation

Artesian Resources Corp operates as a holding company based in the United States. Through its subsidiaries, it offers water, wastewater, and other services in Delaware, Maryland, and Pennsylvania. The Group distributes and sells water, including water for public and private fire protection, to residential, commercial, industrial, municipal, and utility customers. Additionally, it is involved in contract water and wastewater operations; offers wastewater services, and water, sewer, and internal Service Line Protection Plans. The Group operates its businesses mainly through one reportable segment, the Regulated Utility segment.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: